Serotonin receptor antagonist explained

A serotonin antagonist, or serotonin receptor antagonist, is a drug used to inhibit the action of serotonin and serotonergic drugs at serotonin (5-HT) receptors.

Types

5-HT2A antagonists

Antagonists of the 5-HT2A receptor are sometimes used as atypical antipsychotics (contrast with typical antipsychotics, which are purely dopamine antagonists).

They include, but are not limited to:

5-HT2A/2C antagonists

5-HT3 antagonists

Another subclass consists of drugs selectively acting at the 5-HT3 receptors, and thus are known as 5-HT3 antagonists. They are efficacious in treating chemotherapy-induced emesis and postoperative nausea and vomiting.[1]

They include, but are not limited to:

Other 5-HT3 antagonists have been considered for use in the treatment of irritable bowel syndrome:

Also, the antidepressant mirtazapine acts as a 5-HT3 antagonist.

Non-selective 5-HT antagonists

Although some non-selective serotonin antagonists may have a particular affinity for a specific 5-HT receptor (and thus may be listed below e.g., methysergide), they still may also possess a generalised non-selective action.

They include, but are not limited to:

Antihistamines with antiserotonergic activity

Others

See also

Notes and References

  1. Lindley . C. . Blower . P. . Oral serotonin type 3-receptor antagonists for prevention of chemotherapy-induced emesis . American Journal of Health-System Pharmacy . 57 . 18 . 1685–1697 . 2000 . 11006796 . 10.1093/ajhp/57.18.1685. free .
  2. Pittler MH, Ernst E . Max H . Pittler . Feverfew for preventing migraine . Cochrane Database of Systematic Reviews . 2004 . 1 . 10.1002/14651858.CD002286.pub2 . 14973986 . CD002286.
  3. Mittra . S . Datta . A . Singh . SK . Singh . A . 5-Hydroxytryptamine-inhibiting property of Feverfew: role of parthenolide content . Acta Pharmacologica Sinica . December 2000 . 21 . 12 . 1106–14 . 11603284 .
  4. Chairungsrilerd . Nattaya . Furukawa . K.-I. . Ohta . Tomihisa . Nozoe . Shigeo . Ohizumi . Yasushi . γ-Mangostin, a novel type of 5-hydroxytryptamine 2A receptor antagonist . Naunyn-Schmiedeberg's Archives of Pharmacology . 12 December 1997 . 357 . 1 . 25–31 . 10.1007/pl00005134 . 9459569 . 24972810 .